切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DCLK2 - Insulin and Insulin-like Receptors - P110 - Microtubules/Tubulins

15件产品中的 1-10

页面
每页
清除全部
  1. CMPD-1
    B6962 CMPD-1
    Target: Microtubules/Tubulins|MK2
    Summary: p38α介导的MK2a磷酸化的抑制剂
      <34.94 mg/mL
      <34.94 mg/mL
  2. Dolastatin 10
    B1035 Dolastatin 10
    中文名: 尾海兔素10
    Target: Microtubules/Tubulins
    Summary: 抗肿瘤剂
      ≥67.2 mg/mL
      insoluble in H2O
  3. PP121
    B2172 PP121
    Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|Hck
    Summary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  4. Nocodazole
    A8487 Nocodazole
     1 Citation
    中文名: 诺考达唑
    Target: Microtubules/Tubulins
    Summary: 微管蛋白产生抑制剂,抗肿瘤剂
      ≥15.066 mg/mL
      insoluble in H2O
  5. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  6. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  7. Epothilone B (EPO906, Patupilone)
    A1630 Epothilone B (EPO906, Patupilone)
    中文名: 埃博霉素B,帕土匹龙
    Target: Microtubules/Tubulins
    Summary: 大环内酯物抗癌试剂
      ≥25.4 mg/mL
      insoluble in H2O
  8. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  9. ABT-751 (E7010)
    A1493 ABT-751 (E7010)
     1 Citation
    Target: Microtubules/Tubulins
    Summary: 微管聚合抑制剂,抗有丝分裂。
      ≥18.55 mg/mL
      insoluble in H2O
  10. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O

15件产品中的 1-10

页面
每页